6'-o-methylguanosine has been researched along with Neurodegenerative Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bammler, TK; Beyer, RP; Churchwell, M; Doerge, DR; Fry, RC; Kavanagh, TJ; Kisby, GE; Lasarev, MR; Meira, LB; Palmer, VS; Ramos-Crawford, AL; Ren, X; Samson, LD; Spencer, PS; Sullivan, RC; Zarbl, H | 1 |
1 other study(ies) available for 6'-o-methylguanosine and Neurodegenerative Diseases
Article | Year |
---|---|
The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.
Topics: Animals; Binding Sites; Brain; Brain Neoplasms; Cycadopsida; DNA Damage; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Profiling; Gene Regulatory Networks; Guanosine; Humans; Liver; Male; Methylazoxymethanol Acetate; Mice; Mice, Inbred C57BL; Models, Biological; Mutagens; Neurodegenerative Diseases; Organ Specificity; Signal Transduction; Transcription Factors; Transcription, Genetic; Tumor Suppressor Proteins | 2011 |